Хайлтын үр дүнгүүд - Caroline Almon
- 3-н 1 - 3 үр дүнгүүдийг харуулж байна
-
1
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial -н Mrinal M. Gounder, Melissa L. Johnson, Rebecca S. Heist, Geoffrey I. Shapiro, Sophie Postel‐Vinay, Frederick H. Wilson, Elena Garralda, Gerburg M. Wulf, Caroline Almon, Salah Nabhan, Elia Aguado-Fraile, Peng He, Mathilde Romagnoli, Mohammad Ismail Hossain, Rohini Narayanaswamy, Amel Sadou-Dubourgnoux, Michael K. Cooper, Vasileios Askoxylakis, Howard A. Burris, Josep Tabernero
Хэвлэсэн 2025Artigo -
2
Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to... -н Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi, Alice S. Mims, Keith W. Pratz, Michael R. Savona, Anthony S. Stein, Richard M. Stone, Eric S. Winer, Christopher S. Seet, Hartmut Döhner, Daniel A. Pollyea, James McCloskey, Olatoyosi Odenike, Bob Löwenberg, Gert J. Ossenkoppele, Prapti A. Patel, Mikhail Roshal, Frederik Lersch, Salah Nabhan, Sung Choe, Hongfang Wang, Lei Hua, Caroline Almon, Michael K. Cooper, Martin S. Tallman
Хэвлэсэн 2018Artigo -
3
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study -н Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi, Alice S. Mims, Keith W. Pratz, Michael R. Savona, Anthony S. Stein, Richard M. Stone, Eric S. Winer, Christopher S. Seet, Hartmut Döhner, Daniel A. Pollyea, James McCloskey, Olatoyosi Odenike, Bob Löwenberg, Gert J. Ossenkoppele, Prapti A. Patel, Mikhail Roshal, Mark G. Frattini, Frederik Lersch, Aleksandra Franovic, Salah Nabhan, Bin Fan, Sung Choe, Hongfang Wang, Bin Wu, Lei Hua, Caroline Almon, Michael K. Cooper, Hagop M. Kantarjian, Martin S. Tallman
Хэвлэсэн 2020Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Chemotherapy
Gastroenterology
Induction chemotherapy
Oncology
Surgery
Adverse effect
Amino acid
Anemia
Biochemistry
Biology
Chemistry
Chemotherapy regimen
Gene
Genetics
IDH1
IDH2
Methionine
Methionine Adenosyltransferase
Mutation
Myeloid leukemia
Pharmacodynamics
Pharmacokinetics
Pharmacology
Tolerability